Clinical Trial

Clinical Trial Volunteers in Portugal Keep Getting Their Medicine Free After the Study Ends, Until the SNS Can Supply It, Under an Ordinance in Force From Saturday

Portaria 465/2026/1 makes trial sponsors keep giving participants the tested medicine free after their part ends, if the investigator judges it indispensable and no equivalent treatment exists, until it reaches the market and the SNS.

23 October 2026

News

Bial Shelves the BIA 28-6156 Parkinson Phase 2 Trial After the Trofa Pharma Reads No Efficacy Signal at the Primary Endpoint — Five-Year Disease-Modification Programme Folded as the Compound Misses Its Placebo Comparator

Bial-Portela & C. (Bial), the Trofa-based family-owned pharmaceutical company that remains Portugal's largest independent drug developer, confirmed on Monday 9 June 2026 that it has discontinued the clinical development of BIA 28-6156 , the...

11 June 2026

Subscribe to The Portugal Brief

Portugal news, guides, and resources in English. Choose from four free newsletters: the daily brief every morning, plus weekly local briefs for Lisbon, Porto, and Braga. No paywall.

Choose your newsletters The daily brief (every morning) The Braga Brief (Fridays) The Lisboa Brief (Saturdays) The Porto Brief (Sundays)

Check your inbox for a sign-in link. Welcome aboard.

The Portugal Brief

Published by Thrifty Explorations LLC

Subscribe
About
Editorial Standards
Partner with Us
Privacy
Terms